Rankings
▼
Calendar
MIRM
Mirum Pharmaceuticals, Inc.
$5B
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$65,000
Net Income
-$67,000
EPS (Diluted)
$-0.01
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
← FY 2018
All Quarters
Q4 2018 →
MIRM Q3 2018 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
